CureVac’s $250 Million Common Shares Offering

NautaDutilh and Davis Polk advised CureVac on the offering, while Latham & Watkins advised the underwriters involved.CureVac N.V. announced the pricing of 27,027,028 common shares in…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now